Drug Shortage Report for ACT PROGESTERONE INJECTION
Report ID | 149602 |
Drug Identification Number | 02446820 |
Brand name | ACT PROGESTERONE INJECTION |
Common or Proper name | PROGESTERONE 500MG/10ML INJ |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PROGESTERONE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-11-16 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-08-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-08-18 | French | Compare |
v7 | 2022-08-18 | English | Compare |
v6 | 2022-08-08 | French | Compare |
v5 | 2022-08-08 | English | Compare |
v4 | 2022-02-04 | French | Compare |
v3 | 2022-02-04 | English | Compare |
v2 | 2021-11-18 | French | Compare |
v1 | 2021-11-18 | English | Compare |
Showing 1 to 8 of 8